Patent · US Active

T cell receptor antigen binding molecules and methods of use thereof

US11820823B2 · kind B2 · utility

0Cited by

2References

18Claims

0Family size

Assignee

Kite Pharma, Inc. · US

Inventors

Stephanie Astrow · Los Angeles, US
Stuart A. Sievers · San Fernando, US
Jed Wiltzius · Santa Monica, US

Key dates

Filing date	Oct 26, 2018
Grant date	Nov 21, 2023
Priority date	—
Expiry date	Jun 8, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/7051
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Isolated antigen binding molecules that specifically bind to a polypeptide comprising the alpha chain of the constant region of a T cell receptor (TCR) are provided. The antigen binding molecules may be used in the methods provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.